1-3 of 3
Nicolas Gazeau
Close
Sort by
Journal Articles

Genomic profiling of mycosis fungoides identifies patients at high risk of disease progression

Léa Fléchon, Inès Arib, Ankit K. Dutta, Lama Hasan Bou Issa, Romanos Sklavenitis-Pistofidis, Rémi Tilmont, Chip Stewart, Romain Dubois, Stéphanie Poulain, Marie-Christine Copin, Sahir Javed, Morgane Nudel, Doriane Cavalieri, Guillaume Escure, Nicolas Gower, Paul Chauvet, Nicolas Gazeau, Cynthia Saade, Marietou Binta Thiam, Aïcha Ouelkite-Oumouchal, Silvia Gaggero, Émeline Cailliau, Sarah Faiz, Olivier Carpentier, Nicolas Duployez, Thierry Idziorek, Laurent Mortier, Martin Figeac, Claude Preudhomme, Bruno Quesnel, Suman Mitra, Franck Morschhauser, Gad Getz, Irene M. Ghobrial, Salomon Manier
Journal: Blood Advances
Blood Adv (2024) 8 (12): 3109–3119.
https://doi.org/10.1182/bloodadvances.2023012125
Published: 2024
Includes: Supplemental data
Journal Articles

Timing of anti–PD-L1 antibody initiation affects efficacy/toxicity of CD19 CAR T-cell therapy for large B-cell lymphoma

Alexandre V. Hirayama, Erik L. Kimble, Jocelyn H. Wright, Salvatore Fiorenza, Jordan Gauthier, Jenna M. Voutsinas, Qian Wu, Cecilia C. S. Yeung, Nicolas Gazeau, Barbara S. Pender, Delaney R. Kirchmeier, Aiko Torkelson, Abigail N. Chutnik, Ryan D. Cassaday, Aude G. Chapuis, Damian J. Green, Hans-Peter Kiem, Filippo Milano, Mazyar Shadman, Brian G. Till, Stanley R. Riddell, David G. Maloney, Cameron J. Turtle
Journal: Blood Advances
Blood Adv (2024) 8 (2): 453–467.
https://doi.org/10.1182/bloodadvances.2023011287
Published: 2024
Includes: Supplemental data
Journal Articles

Effective anti-BCMA retreatment in multiple myeloma

Clinical Trials & Observations
Nicolas Gazeau, David Beauvais, Ibrahim Yakoub-Agha, Suman Mitra, Timothy B. Campbell, Thierry Facon, Salomon Manier
Journal: Blood Advances
Blood Adv (2021) 5 (15): 3016–3020.
https://doi.org/10.1182/bloodadvances.2021004176
Published: 2021